Speaker illustration

undefined undefined undefined

Persistence with macitentan versus other endothelin receptor antagonists in patients with pulmonary arterial hypertension: experience from a real-world data repository in the USA

Event: ESC Congress 2022

Topic: Treatment

Session: Hypertension - Treatment lifestyle and pharmacotherapy

Thumbnail

ESC 365 is supported by